CHINARES PHARMA (03320): Dong-E-Jiao's net profit in the first quarter was 4.55 billion yuan, a year-on-year increase of 7.12%.
China Resources Pharmaceutical Group Limited (03320) released the performance of Donge Ejiao Co., Ltd. (Donge Ejiao) for the three months ending March 31, 2026. The total operating revenue is about 1.814 billion yuan, an increase of 5.52% year-on-year; the net profit is 455 million yuan, an increase of 7.12% year-on-year.
CHINARES PHARMA (03320) releases the performance of Dong-E-E-Jiao Co., Ltd. (Dong-E-E-Jiao) for the three months ending March 31, 2026. The total operating income is approximately 1.814 billion yuan, a year-on-year increase of 5.52%; the net profit is 455 million yuan, a year-on-year increase of 7.12%.
Related Articles

MILLIONHOPE IND (01897) cancelled 328,000 shares repurchased on April 24th.

On April 24th, KEEP (03650) spent 880,400 Hong Kong dollars repurchasing 300,000 shares.

FSM Holdings (01721)'s sales revenue from its manufacturing business in the first quarter decreased by approximately 52% to 59% year-on-year.
MILLIONHOPE IND (01897) cancelled 328,000 shares repurchased on April 24th.

On April 24th, KEEP (03650) spent 880,400 Hong Kong dollars repurchasing 300,000 shares.

FSM Holdings (01721)'s sales revenue from its manufacturing business in the first quarter decreased by approximately 52% to 59% year-on-year.

RECOMMEND

The Great Transformation Of The Hong Kong Automotive Market
23/04/2026

Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026

Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026


